We are very proud to bring you this inaugural issue of Neurology and Clinical Neuroscience.

The Japanese Society of Neurology (JSN) was originally founded in 1902 with the establishment of the Japanese Society of Internal Medicine. In 1935 JSN changed its name to the Japanese Society of Psychiatry and Neurology (JSPN) to recognize and signify that the organization comprised psychiatrists as well as neurologists. In 1959 JSN re-established itself by separating from JSPN and becoming an independent organization. Since then, JSN has developed steadily and we currently have 8,852 members and 4,866 board-certified neurologists.

JSN's mission is to develop neurology and neurological services for people in Japan and overseas. To help us fulfill our mission, one of our five key goals is to internationalize JSN. As a country, Japan is highly evaluated across the world as a place where people can enjoy a safe, healthy, and long life. This achievement would not be possible without abundant communication and informational/technological exchanges with people and institutions in various countries, areas, and fields.

In the field of neurology, of course, the importance of internationalization is very apparent. International activity is critical to the successful development of neurology via contemporary understanding of advanced science and healthcare approaches from around the world. We must also keep in mind that there are many communities which can use our hard-won expertise, particularly in Asia and other developing areas.

As mentioned above, the present JSN was re-established in 1959 and only two years later our founders established the Asian and Oceanian Association of Neurology (AOAN) and held the 1st Asian and Oceanian Congress of Neurology (AOCN) meeting in Tokyo. We are very proud of the fact that JSN made concrete steps to be an international organization its earliest days.

To further this internationalizing purpose, JSN is pursuing various activities, including international collaborations with the World Federation of Neurology (WFN) and other international societies, collaborations with neurological societies of other countries, working with WFN on its Asia Initiative, bidding for WCN2017, and internationalizing our annual meetings. The launch of this English-language journal is one of the most important projects in our effort to further the internationalization, development, and outreach of JSN.

Our aim is for Neurology and Clinical Neuroscience to bring high quality manuscripts on neurology and clinical neuroscience to our readers. The original articles that will appear in this publication will cover not only broad areas of clinical neuroscience but also a wide scope of basic research in neurology, with emphasis on research that explores the frontiers of clinical neuroscience to elucidate the mechanisms of neurological disease and clinical trials that promise to develop better treatments for, and prevention of, neurological diseases. In addition, Neurology and Clinical Neuroscience will include reviews, case reports, images, reports on trends in the field, commentaries and Letters to the Editor that will each provide the reader with new insights into neurology and clinical neuroscience.

In closing, I would like to thank you for reading this inaugural issue and for your support. I am confident that Neurology and Clinical Neuroscience will greatly contribute to the development and advancement of neurology in all its various fields and around the world.

Thumbnail image of